United Therapeutics Corporation Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Ladenburg Thalmann Upgrades United Therapeutics Corp. (UTHR) to Buy
October 28, 2016 7:43 AM EDTLadenburg Thalmann upgraded United Therapeutics Corp. (NASDAQ: UTHR) from Neutral to Buy with a price target of $138.00.
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $116.34 yesterday.
... MoreUnited Therapeutics (UTHR) Tops Q3 EPS by 16c
October 27, 2016 7:59 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.50, $0.16 better than the analyst estimate of $3.34. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $402.35 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
... More